Edson Cassinela

Dr. Edson Cassinela

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
ABAntuani Rafael Baptistella
Antuani Rafael Baptistella
MLMichele Christine Landemberger
Michele Christine Landemberger
MDMarcos Vinicios Salles Dias
Marcos Vinicios Salles Dias
FGFernanda Salgueiredo Giudice
Fernanda Salgueiredo Giudice
BRBruna Roz Rodrigues
Bruna Roz Rodrigues
VMVilma Regina Martins
Vilma Regina Martins

1 December 2018 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
MCMarina Souza Cunha
Marina Souza Cunha
NTNatália Martins Travenzoli
Natália Martins Travenzoli
RFRiudo de Paiva Ferreira
Riudo de Paiva Ferreira
ECEdson Cassinela
Edson Cassinela
HSHenrique Barbosa da Silva
Henrique Barbosa da Silva
DLDenilce Lopes
Denilce Lopes
The genus Melipona is subdivided into four subgenera based on morphological characteristics, and two groups based on cytogenetic patterns. The cytogenetic information on this genus is still scarce, therefore, the goal of this study was to characterize Melipona paraensis, Melipona puncticollis, and Melipona seminigra pernigra using the following techniques: C-banding, DAPI/CMA3 fluorochromes, and FISH with an 18S rDNA probe. Melipona paraensis (2n=18) and M. seminigra pernigra (2n=22) were classified as high heterochromatin content species (Group II). Their euchromatin is restricted to the ends of the chromosomes and is CMA3+; the 18S rDNA probe marked chromosome pair number 4. Melipona puncticollis (2n=18) is a low heterochromatin content species (Group I) with chromosome pair number 1 marked with CMA3 and 18S rDNA. Low heterochromatin content is a putative ancestral karyotype in this genus and high content is not a monophyletic trait (Melikerria presents species with both patterns). Differences concerning the karyotypic characteristics can be observed among Melipona species, revealing cytogenetic rearrangements that occurred during the evolution of this genus. Studies in other species will allow us to better understand the processes that shaped the chromatin evolution in Melipona.

5 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
CSCruz Sebastião
Cruz Sebastião
ECEdson Cassinela
Edson Cassinela
VMVilma Manuel
Vilma Manuel
WMWilma Matary
Wilma Matary
MNMaria Nkuku
Maria Nkuku
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
Background: Malaria continues a concern in Angola. Liver dysfunction is a relevant feature of malaria. There is no published study exploring liver function dynamics during P.falciparum infection in Angola.Objectives: We investigated the dynamics of liver function among patients with malaria in Luanda, Angola.Methods: This was a cross-sectional study performed with 199 malaria patients, from March-August 2023.Results: About 71% of the patients had low parasitemia, moderate disease(54%), and used Artesunato(39.7%). Decrease in ALT(68.7 to 50.7) was observed from non-severe to severe with increases in AST(56.6 to 134, p<0.05), GGT(51.2 to 99.0), and Bilirubin(0.72 to 1029). We observed higher ALT values in patients using Artimeter, while higher AST and GGT in patients using Artesunate. Higher Bilirubin was observed in patients treated with Coarten. Differences in AST values depending on the antimalarial used were significant(p<0.05). AB blood group presented high AST and GGT values, group B presented high ALT while high Bilirubin was observed in group O. Differences in GGT depending on the blood groups were significant(p<0.05). Elevated ALT, AST, GGT, and Bilirubin were observed in Rh-positive.Conclusions: Several malarian patients could present high AST, ALT, GGT, and Bilirubin values indicating putative liver failure during malaria treatment in Angola.

1 January 2022 in Journal Health NPEPS
Verified
Journal Article
Open access
PDF file
VSVerónica Muhangueno Mateus Santana
Verónica Muhangueno Mateus Santana
ECEdson Cassinela
Edson Cassinela
MCMauricio da Costa
Mauricio da Costa
SSSilvana da Rocha Silveira
Silvana da Rocha Silveira
CSCarlos Alberto Pinto de Sousa
Carlos Alberto Pinto de Sousa
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
Objetivo: avaliar os fatores associados ao baixo Apgar em recém-nascidos de Angola. Método: estudo analitíco e transversal, quali-quantitativo entre março e maio de 2021, realizado no Hospital Geral de Luanda, Angola. Realizou-se entrevistas em sala de espera e consulta aos prontuários das parturientes. Os dados foram analisados pelo teste qui-quadrado (X2) e regressão logística. Resultados: prevaleceu parturientes entre 19-35 anos (70,0%), 7º-9º ano (57,5%), multíparas (75%), multigestas (75,0%), sem histórico de aborto (72,5%), idade gestacional de 40 semanas (60,0%), usuárias de bebidas alcoólicas (77,5%), baixa frequência de consultas pré-natais (52,5%), com parto natural (82,5%) e recém-nascidos com peso normal (52,5%). Mulheres de região periurbana [OR:6,85 (95% CI:0.65-71,2), p=0,108] e rural [OR:4,47 (95% CI:0.47-48,4), p=0,184] apresentaram maior chance de terem recém-nascidos com baixo Apgar, assim como as usuárias de álcool [OR:3,28 (95% CI:0,58-18,3), p=0,176] e recém-nascidos que nasceram com peso normal [OR:1,75 (95% CI:0,49–6,22), p=0,387]. Não houve associação estatística entre os dados sociodemográficos e maternos. Conclusão: a faixa etária, local de residência, consumo de álcool materno e peso do recém-nascido podem implicar em baixo Apgar.

11 January 2023 in Health Science Reports
Verified
Journal Article
Open access
CSCruz Sebastião
Cruz Sebastião
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
NFNgiambudulu M. Francisco
Ngiambudulu M. Francisco
ECEdson Cassinela
Edson Cassinela
AMAntónio Mateus
António Mateus
JMJoana Morais
Joana Morais
Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is a public health concern. Until 2021, more than 2 million cumulative deaths were reported worldwide. Herein, we investigated the immune profile of healthcare professionals 6 months after vaccination or exposure to SARS‐CoV‐2 in Angola.Methods: This was a prospective study conducted with 1068 Angolan healthcare professionals between August and December 2021. Participants were screened for the presence of IgG and IgM against SARS‐CoV‐2.Results: About 9.6% and 98.2% of the participants had prior exposure to SARS‐CoV‐2 or vaccination against it, respectively. Participants aged between 20 and 40 years (11.2%), female (12.4%), with higher educational level (12.8%), from Luanda (60.3%), and nonhealthcare professionals (8.1%) were the most affected by the SARS‐CoV‐2. Gender, education, and local residence were related to SARS‐CoV‐2 exposure (p < 0.05). About 7.3% and 98% of the exposed population developed IgM and IgG after 3 months of exposure, respectively. The AstraZeneca vaccine was the most used, followed by the Jonhson & Johnson and Sputinik. Almost all (98%) participants vaccinated with AstraZeneca had immunity >3 months. Individuals who received only the first dose regardless of the type of vaccine had a higher immunity duration (>3 months) than those who received two doses. For individuals who received the Sputnik and Johnson, the average immunity was lower (<3 months), especially among those who were older (over 40 years old) and exposed to SARS‐CoV‐2.Conclusion: We observed a high adherence rate to vaccination and a long immunity duration. The immunity duration depended on the type of vaccine. Further studies on the immunity profile in the population exposed to SARS‐CoV‐2 must be carried out in the general population from Angola to assess antibody‐waning periods.

4 December 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
TPTelma Patrícia Pereira Paulo
Telma Patrícia Pereira Paulo
ECEdson Cassinela
Edson Cassinela
CSCruz Sebastião
Cruz Sebastião
Background: Resistance to antimalarial drugs often used in emerging countries, including combination therapies, has forced scientists to search for and develop drugs with novel mechanisms of action, especially resistance to Plasmodium falciparum and Plasmodium vivax, which are highly prevalent in Southeast Asia, Africa, and South America. Objective: evaluate whether there is a relationship between urinalysis and resistance to in-hospital treatment of malaria in Angola. Methodology: This was a cross-sectional, prospective study with a quantitative approach. Results: of the 214 patients, the resistance rate was 24.1%, men (53.6%), between 21 and 40 years old (72.7%), employees (46.4%), from peri-urban regions (77.7%), treated with artemether (90.9), with high parasitemia (57.7%) and after 5 days of treatment, remained hospitalized (61.4%). Was a significant relationship between resistance in unemployed individuals [OR: 0.03 (95% CI: 0.01-0.29), p =0.003] and high levels of parasitemia [OR: 1.09 (95% CI: 1.09-3.95), p=0.040], remained hospitalized for more than 5 days [OR: 5.28 (95% CI: 0.65-43.1), p=0.121] and death [OR: 2.59 (95% CI: 0.32-20.9), p=0.371] when compared with other subgroups. Was a significant relationship between resistance to clear urine [OR: 5.55 (95% CI: 0.72-42.7), p =0.016], few urinary crystals [OR: 11.3 (95% CI: 5.07-25.3), p <0.001] and who presented some microorganisms that were not bacteria or fungi [OR: 3.02 (95% CI: 1 .32-6.90), p=0.009]. Conclusion: urine results, especially the appearance of cloudy urine, the presence of few crystals, and the presence of other microorganisms that are not bacteria or fungi, may be clear signs of resistance to hospital treatment with injectable antimalarials.